Loading...
BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma
BACKGROUND: Nonfunctioning pituitary adenoma (NFPA) and growth hormone pituitary adenoma (GHPA) are major subtypes of pituitary adenomas (PAs). The primary treatment is surgical resection. However, radical excision remains challenging, and few effective medical therapies are available. It is urgent...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594556/ https://ncbi.nlm.nih.gov/pubmed/32246150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa084 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|